Clinic
Oregon State University Student Health Services
Oregon State University Student Health Services was paid $1.43M by Medicaid between Jan 2018 and Nov 2024, across 27 billing codes. Its largest line is S4993, Contraceptive pills for birth control — 47% of everything it billed.
33Billing provider infoOREGON STATE UNIVERSITY STUDENT HEALTH SERVICES
CORVALLIS, OR 97331
CORVALLIS, OR 97331
33aNPI1316048531assigned 09/26/2006
33bProvider typeStudent Health Clinic/Center
28Total paid$1.43M
24GClaims16,885
24DCodes billed27
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,402 | $63K | |
| 2019 | 3,214 | $305K | |
| 2020 | 3,321 | $293K | |
| 2021 | 2,387 | $185K | |
| 2022 | 2,540 | $180K | |
| 2023 | 2,036 | $167K | |
| 2024incomplete | 1,985 | $239K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S4993 | Contraceptive pills for birth control | 47% | 4,258 | 3,071 | $673K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 37% | 4,585 | 3,944 | $528K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 3.9% | 72 | 72 | $56K |
| 90620 | 2.8% | 517 | 401 | $41K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 2.4% | 41 | 40 | $34K |
| S4930 | 2.3% | 3,290 | 3,134 | $33K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 1.6% | 1,298 | 1,296 | $23K |
| 90675 | 1.1% | 76 | 32 | $16K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 894 | 702 | $7K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 137 | 116 | $7K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 186 | 136 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 185 | 135 | $3K |
15 more codes
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 40 | $2K |
| A4267 | Contraceptive supply, condom, male, each | <1% | 962 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 27 | $935.81 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 18 | $820.96 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 13 | $729.00 |
| 90734 | <1% | 15 | $607.92 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 15 | $512.89 |
| 90674 | <1% | 18 | $270.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 99 | $212.46 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12 | $202.32 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 72 | $176.80 |
| 99401 | <1% | 12 | $175.00 | |
| 90756 | <1% | 13 | $110.20 | |
| 86580 | <1% | 17 | $84.90 | |
| 86592 | <1% | 13 | $24.94 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPROSOSKI, ROBIN (SUPPORT SERVICES MANAGER)